The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
about
Monoclonal antibodies for the treatment of cancerNimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II studyDelineating the functional map of the interaction between nimotuzumab and the epidermal growth factor receptor.Nimotuzumab enhances the radiosensitivity of cancer cells in vitro by inhibiting radiation-induced DNA damage repair.A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancerEGFR-Targeting as a Biological Therapy: Understanding Nimotuzumab's Clinical EffectsRemission of lung metastasis due to single nimotuzumab treatment: A preliminary observation and the first world report.Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs.
P2860
Q27025966-E9706111-86B0-43AF-9306-92E3C30BE31CQ33779303-6984FB83-D719-4F59-9146-57CB3A1FF26DQ34223866-D7FB9689-9059-4102-91F5-80D5C5EEB323Q34970294-357DDD72-7020-4982-A00E-86B4D043383FQ36214463-D2B4A91E-2F1B-4BAD-8143-A872908CFAC2Q36656070-5AA44335-9E89-42B4-B602-C0E3314B743BQ37132708-BF8B1720-16C3-469A-A713-B3AA99DDA7F7Q37150904-BB462DBA-0E4E-4AA2-8519-489A347AA3CBQ37714120-D1F16B6D-71CA-416E-AB72-C816D42E931DQ41855293-15032F33-2BA7-44B5-9CB4-A22417878754
P2860
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@ast
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@en
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@nl
type
label
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@ast
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@en
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@nl
prefLabel
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@ast
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@en
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@nl
P2860
P356
P1476
The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.
@en
P2093
William Boland
P2860
P304
P356
10.2147/BTT.S8617
P577
2010-11-09T00:00:00Z